UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017048
Receipt number R000019774
Scientific Title Analysis of association between disease of the oral cavity and IgA nephropathy
Date of disclosure of the study information 2015/04/06
Last modified on 2022/10/10 11:04:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of association between disease of the oral cavity and IgA nephropathy

Acronym

Analysis of association between disease of the oral cavity and IgA nephropathy

Scientific Title

Analysis of association between disease of the oral cavity and IgA nephropathy

Scientific Title:Acronym

Analysis of association between disease of the oral cavity and IgA nephropathy

Region

Japan


Condition

Condition

IgA nephropathy

Classification by specialty

Medicine in general Nephrology Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Our aim is to investigate whether disease of the oral cavity associate with IgA nephropathy.

Basic objectives2

Others

Basic objectives -Others

Disease activity of IgA nephropathy

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

We check disease of the oral cavity and renal function regularly,
We check association between disease of the oral cavity and eGFR, urinary protein, hematuria, dialysis and death after 5years.

Key secondary outcomes

1.Cnm positive Streptococcus in saliva is a risk factor of IgA nephropathy.
2.Degree of dental caries is associated with degree of IgA nephropathy.
3.Degree of periodontal disease is associated with degree of IgA nephropathy.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who have been diagnosed with IgA nephropathy by renal biopsy.
Patients who agree to participate in the study.

Key exclusion criteria

Patients who are taking steroid therapy.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Taro
Middle name
Last name Misaki

Organization

Seirei Hamamatsu General Hospital

Division name

Division of Nephrology

Zip code

830-8558

Address

2-12-12 Sumiyoshi, naka-ku, Hamamatsu, Shizuoka, 430-8558 Japan

TEL

053-474-2222

Email

misakitar@sis.seirei.or.jp


Public contact

Name of contact person

1st name Taro
Middle name
Last name Misaki

Organization

Seirei Hamamatsu General Hospital

Division name

Division of Nephrology

Zip code

430-8558

Address

2-12-12 Sumiyoshi, naka-ku, Hamamatsu, Shizuoka, 430-8558 Japan

TEL

053-474-2222

Homepage URL


Email

misakitar@sis.seirei.or.jp


Sponsor or person

Institute

Division of Nephrology, Seirei Hamamatsu General Hospital

Institute

Department

Personal name



Funding Source

Organization

Division of Nephrology, Seirei Hamamatsu General Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Department of Pediatric Dentistry, Graduate School of Dentistry, Osaka University

Name of secondary funder(s)

Department of Pediatric Dentistry, Graduate School of Dentistry, Osaka University


IRB Contact (For public release)

Organization

Division of Nephrology, Seirei Hamamatsu General Hospital

Address

2-12-12 nakaku sumiyoshi hamamatsu, Japan

Tel

053-474-2222

Email

misakitar@sis.seirei.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖隷浜松病院腎臓内科


Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

120

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

The paper is being submitted.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 03 Month 18 Day

Date of IRB

2015 Year 03 Month 18 Day

Anticipated trial start date

2015 Year 04 Month 06 Day

Last follow-up date

2021 Year 04 Month 06 Day

Date of closure to data entry

2021 Year 10 Month 06 Day

Date trial data considered complete

2021 Year 10 Month 06 Day

Date analysis concluded

2022 Year 04 Month 06 Day


Other

Other related information

Observational study


Management information

Registered date

2015 Year 04 Month 05 Day

Last modified on

2022 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019774


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name